May 12 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI - News), the developer and marketer of nutritional supplements under the Iceland Health®, Chromax® and Diabetes Essentials® brands that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and reduce chronic joint pain, today announced financial results for the third quarter and the first nine months of fiscal year 2009 ended March 31, 2009.
For the quarter the Company reported total revenues of $8.6 million compared to $10.8 million in the comparable quarter last year. Net loss for the quarter was $0.4 million, or $(0.01) per fully diluted share, compared to a net loss in the comparable quarter last year of $8.2 million, or $(0.13) per fully diluted share. The reduction in net loss is largely due to a decrease in operating expenses as the Company continues to calibrate its spending to achieve the most effective mix of marketing spend and economic efficiencies.